Physician profile
Heather D Kaufman
NPI 1710007091
$8,279.57
in general payments reported to CMS, 2019-2025
23 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $63.70 · 2021: $3,277 · 2022: $3,315 · 2023: $509 · 2024: $311 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,818.86 | 2019-2024 | Collagenase Santyl, Grafix Pl |
| Summit Surgical Corp. | $2,400.00 | 2022 | |
| Paragon 28, INC. | $1,086.32 | 2019-2021 | |
| Organogenesis INC. | $305.57 | 2021-2025 | Via Matrix, Novachor, Puraply |
| Stryker Corporation | $304.60 | 2022-2025 | Ortholoc 2 Lapifuse, Swanson, Augment Injectable |
| Horizon Therapeutics Plc | $251.41 | 2019-2023 | Krystexxa |
| Kerecis Limited | $180.01 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Rsw Medical Company, INC. | $118.91 | 2019 | |
| Depuy Synthes Sales INC. | $113.08 | 2024 | N/A, Fibergraft Aeridyan Matrix, Motoband |
| Vaporox, INC. | $99.88 | 2023 | Vht-200 Wound Treatment System |
| Tactile Systems Technology INC | $95.00 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $88.23 | 2019 | |
| Triad Life Sciences INC. | $80.07 | 2022 | |
| Heron Therapeutics, INC. | $79.94 | 2021-2022 | |
| Solventum Corporation | $66.66 | 2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $48.40 | 2024 | Purified Cortrophin Gel |
| Abbott Laboratories | $27.05 | 2023 | Proclaim |
| Baudax Bio INC. | $22.23 | 2022 | |
| Tenex Health INC. | $20.97 | 2021 | |
| Medtronic, INC. | $20.05 | 2022 | |
| Celularity INC. | $18.00 | 2019 | |
| Nevro Corp. | $17.70 | 2023 | Senza |
| Bioventus LLC | $16.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.